Are fighter pilots at greater risk for prostate cancer? The Air Force is now asking

The Air Force has begun to look at whether there’s increased risk for prostate cancer among its fighter pilots. A new investigation by McClatchy shows just how serious the problem may be. The fighter pilot study was requested by Air Force Chief of Staff Gen. David Goldfein after he was contacted by concerned veterans service organizations in 2018, according to […]

Continue reading »

AUA: Atenolol linked to drop in low-, intermediate-risk prostate cancer

(HealthDay)—Atenolol is associated with a reduction in incident intermediate- and low-risk prostate cancer (PCa), according to a study presented at the annual meeting of the American Urological Association, held from May 3 to 6 in Chicago. Ali Zahalka, M.D., Ph.D., from the Albert Einstein College of Medicine and Montefiore Medical Center in Bronx, New York, and colleagues conducted a retrospective […]

Continue reading »

Metastatic prostate cancer may have its own biomarker, research finds

Prostate cancer can grow slowly and pose little threat to patients, or it can metastasize quickly, causing severe pain and death. But as of now, it’s nearly impossible to determine which type of cancer a patient has during the early stages. Now, University at Buffalo researchers and scientists from Moscow State University are collaborating to determine how a biomarker for […]

Continue reading »

Laser-targeted removal of prostate tumors works as well complete removal of prostate

Researchers from The University of Texas Medical Branch at Galveston, led by prostate cancer treatment pioneer Dr. Eric Walser, have shown that selectively destroying cancerous prostate tissue is as effective as complete prostate removal or radiation therapy while preserving more sexual and urinary function than the other treatments. This study is currently available in Journal of Vascular and Interventional Radiology. […]

Continue reading »

New nanomedicines for a more efficient and less aggressive treatment of prostate cancer

In Europe, prostate cancer is the most common type of cancer among men with an incidence greater than 100 cases per 100,000 individuals. Furthermore, it is currently the second most common cause of cancer-related deaths among men. This pathology mainly affects elderly men: nine in 10 deaths take place after 65 years of age. Therefore, it represents a very serious […]

Continue reading »

Researchers identify protein that contributes to racial disparities in prostate cancer

Cancer researchers have long known that prostate cancer tends to be more common, more aggressive and more resistant to existing treatments in African-Americans than in Caucasian-Americans, but they’re only beginning to understand why. A Roswell Park Comprehensive Cancer Center study published today points to cellular factors that appear to be driving these disparities—mitochondrial differences that prevent formation of the cancer-killing […]

Continue reading »

Prostate cancer: Starving out the enemy

An old military tactic, widely used in Roman and medieval times, is now being put to good use in cancer research. The idea is that if you starve out your enemy—they will either submit or die. And in the race to develop treatments for prostate cancer, starving out those hostile cancer cells is proving effective. Metabolic biologist at the University […]

Continue reading »

Reliance on ‘YouTube medicine’ may be dangerous for those concerned about prostate cancer

The most popular YouTube videos on prostate cancer often offer misleading or biased medical information that poses potential health risks to patients, an analysis of the social media platform shows. Led by researchers at NYU School of Medicine and its Perlmutter Cancer Center, the study of the 150 most-viewed YouTube videos on the disease found that 77 percent had factual […]

Continue reading »

Hormone therapy can make prostate cancer worse, study finds

Scientists at Cedars-Sinai have discovered how prostate cancer can sometimes withstand and outwit a standard hormone therapy, causing the cancer to spread. Their findings also point to a simple blood test that may help doctors predict when this type of hormone therapy resistance will occur. Prostate cancer is the second-leading cause of cancer death in men, behind lung cancer, killing […]

Continue reading »

Large US study targets prostate cancer in black men

(HealthDay)—Black men in the United States have higher rates of aggressive prostate cancer than other males. Now, a $26.5 million study is underway to figure out why. The U.S. National Institutes of Health and the Prostate Cancer Foundation have launched the study to investigate social, environmental and genetic factors behind this disparity. “No group in the world is hit harder […]

Continue reading »
1 2